Index funds vs picking stocks: the honest trade-off
Most professional stock pickers trail the market over the long run, and the winners are concentrated in a handful of stocks. Here is what the evidence actually says — and what each side of the trade-off costs you.
The scoreboard: 25 years of SPIVA
Every six months, S&P Dow Jones Indices publishes the SPIVA scorecard, which asks one blunt question of every actively managed fund: did it beat its benchmark, after fees? The latest edition, the Mid-Year 2026 scorecard published in September 2026 with data to June 30, 2026, gives the same answer the previous 25 years of scorecards have given. Over 15 years, 90.5% of U.S. large-cap funds trailed the S&P 500. Over 20 years, 92.6% did. Over 10 years, 83.3% did.
The short run looks closer but not close: 78.7% trailed over the year to June 2026, and 67.2% trailed in the first half of 2026 alone — a period when mid-cap and small-cap stocks surged and conditions were supposed to favour stock pickers. In full-year 2025, 79% trailed. Across all domestic funds, 93.3% trailed over 15 years.
One rule makes SPIVA hard to argue with: a fund counts as a winner only if it survived the whole period and beat the index. Funds that were closed or merged along the way stay in the count as funds that did not beat it — so the numbers are not flattered by dropping the losers. Past performance is no indication of future results, and the scorecard is a record of a group of funds, not a recommendation of any fund or approach.
Why the winners are so hard to pick
The fund numbers have a deeper cause, and it sits inside the stock market itself. In a landmark 2018 study published in the Journal of Financial Economics, Arizona State professor Hendrik Bessembinder examined every U.S. common stock from 1926 to 2016 and found that just 4% of stocks — 1,092 out of about 25,300 — accounted for all of the stock market's net shareholder wealth creation. The other 96% collectively matched the return of one-month Treasury bills.
Only 42.6% of individual stocks beat Treasury bills over their full listed lifetimes, and the most common lifetime outcome for a single stock was a 100% loss. The median stock's lifetime return was negative. In other words, the market's gains are not spread evenly across its members; they are concentrated in a small minority of big winners, and missing them is the normal outcome for a concentrated bet.
That is the mathematical case for owning the whole haystack rather than hunting for needles. An index fund holds the winners by construction — including the few stocks that drive most of the gains — while a portfolio of a handful of picks can easily hold none of them. Picking stocks is not impossible; it is a bet that you can find the needles, and find them repeatedly, before fees and taxes.
- 15 years90.5% of U.S. large-cap active funds trailed the S&P 500
- 20 years92.6% trailed the S&P 500
- 10 years83.3% trailed the S&P 500
- First half of 202667.2% trailed, despite a backdrop that favoured stock pickers
- All domestic funds, 15 years93.3% trailed their benchmarks
The quiet cost: fees compound too
The second half of the trade-off is cost, and it is where the gap is widest. Morningstar's 2026 U.S. Fund Fee Study, published in May 2026 with data through December 2025, found that passive funds charged an average of 0.10% a year, asset-weighted, against 0.57% for actively managed funds; broad index funds averaged 0.09%. A separate Morningstar analysis from October 2026 put cap-weighted index funds at 0.05% a year against 0.59% for discretionary active funds — about one-twelfth the cost.
A half-point fee gap sounds trivial. Over decades it is not. Take a simple arithmetic illustration: $100,000 growing at an 8% gross return for 30 years. Net of a 0.10% fee it compounds at 7.90% and reaches about $978,686. Net of a 0.57% fee it compounds at 7.43% and reaches about $858,553. The difference is $120,133 — money that went to fees, not to the investor. This is a calculation, not a forecast: actual returns vary, and no fee level can turn a bad market into a good one.
Fees also explain part of the SPIVA result. An active fund must beat its index by its fee, every year, just to break even with it — and then beat it again to win. The lower the fee, the smaller the hurdle. That is why the cheapest funds, whatever their strategy, have historically had the best odds of beating their benchmarks.
The honest trade-off
So what does each side actually give up? An index fund gives up the chance to outperform the market: by design it will trail its index by roughly its fee, and it will hold the overpriced stocks along with the great ones. What it buys is the market's return, broad diversification, tiny costs, and no need to be right about individual companies.
Picking stocks — directly, or through an active fund — buys the chance to outperform the market, and with it the chance to lag it badly. It also costs time, research, trading costs and taxes, and it demands the discipline to hold through the years when the picks look wrong. Some investors genuinely enjoy that work and some are good at it; the evidence says most, professionals included, are not, over long horizons.
There is no single right answer, only a trade-off to price honestly: the odds of outperforming the market, the cost of trying, and how much of your money rides on the attempt. Check the fee before anything else, know whether you are buying the haystack or hunting for needles, and remember that a strategy that needs you to be right twice — on the buy and on the sell — is a harder game than one that needs you to be patient once. Educational content, not investment advice.
